<DOC>
	<DOCNO>NCT00482079</DOCNO>
	<brief_summary>A dose-ranging study MK0431 patient type 2 diabetes inadequate control blood sugar .</brief_summary>
	<brief_title>A Study MK0431 Patients With Type 2 Diabetes ( 0431-010 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Age 21 70 , You man nonpregnant woman Have history type I diabetes You weight loss program ongoing weight loss take weight loss medication You history minor surgery You receive investigational drug within 8 week study start You hepatitis B C</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>